Piper Sandler lowered the firm’s price target on Procter & Gamble to $142 from $150 and keeps a Neutral rating on the shares. The firm notes the company’s exposure to higher resin and other oil derivative costs is more modest compared to its HPC peers at a mid-single digit percentage of COGS.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $166 from $170 at UBS
- 3 Vanguard ETFs Are Beating the S&P 500 in 2026 – Should You Buy?
- 3 Best Dividend Aristocrat Stocks to Buy Now, 04/02/2026
- Procter & Gamble price target lowered to $142 from $156 at TD Cowen
- Procter & Gamble price target lowered to $162 from $171 at Deutsche Bank